Raphael Pharmaceutical Inc (RAPH)
1.54
+0.54
(+54.00%)
USD |
OTCM |
May 21, 11:04
Raphael Pharmaceutical Free Cash Flow (Quarterly): -0.173M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.173M |
| December 31, 2023 | -0.088M |
| September 30, 2023 | -0.501M |
| June 30, 2023 | -0.215M |
| March 31, 2023 | -0.399M |
| December 31, 2022 | -0.277M |
| September 30, 2022 | -0.154M |
| Date | Value |
|---|---|
| June 30, 2022 | -0.248M |
| March 31, 2022 | -0.082M |
| December 31, 2021 | -0.703M |
| September 30, 2021 | -0.281M |
| June 30, 2021 | -0.305M |
| March 31, 2021 | -0.129M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-0.703M
Minimum
Dec 2021
-0.082M
Maximum
Mar 2022
-0.2735M
Average
-0.248M
Median
Jun 2022
Free Cash Flow (Quarterly) Benchmarks
| InspireMD Inc | -5.259M |
| Pluri Inc | -4.291M |
| BiomX Inc | -6.249M |
| Alpha Tau Medical Ltd | -- |
| Holdco Nuvo Group DG Ltd | -- |